Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers
Toulsie Ramtohul(Université Paris Sciences et Lettres), A. Tardivon(Université Paris Sciences et Lettres), Manel Djelouah(Institut Curie), Emmanuelle Menet(Institut Curie), Caroline Malhaire(Université Paris Sciences et Lettres), Luc Cabel(Université de Versailles Saint-Quentin-en-Yvelines), Caroline Nhy(Institut Curie), Émilie Lissavalid(Institut Curie), Lounes Djerroudi(Memorial Sloan Kettering Cancer Center), Louis Redon(Institut Curie), Laura Ikni(Institut Curie), Gabrielle Journo(Institut Curie)
Cited by 122
Related Papers
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
|Breast Cancer Research and Treatment|2018|251
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
|Breast Cancer Research|2020|125
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
|JNCI Cancer Spectrum|2020|60